Ferring Receives U.S. FDA Approval for REBYOTA™ – A Novel First-in-Class Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved REBYOTA™ (fecal microbiota, live-jslm).
A New Approach to Spotting Tumors: Look for Their Microbes – New York Times
New research is revealing that cancer is rife with bacteria and fungi — a rich ecosystem that scientists call the tumor microbiome.
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Cancer-microbe associations have been explored for centuries, but cancer-associated fungi have rarely been examined.